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The objective of this study was to evaluate and compare the
cardiorespiratory and metabolic variables at the peak of exercise (up to
physical exhaustion) and at the anaerobic threshold (AT) during a
ramp-type-ergospirometric test (R-ET) on users and nonusers of oral
contraceptives (OCs). 28 sedentary women divided into 3 groups: 10
nonusers of OCs (22.8±2.4 years); 10 users of OCs of ethinyl-estradiol
(EE) combined with gestodeno (23.4±4.0 years); and 8 users of OCs of
EE combined with desogestrel (23.2±5.0 years). The OC groups
included women undergoing combined monophasic OC for at least 8
months. The volunteers were subjected to a complete clinical check-up,
R-ET on a cycloergometer with power increments of 20 W/min, carried
out on 7th and 10th day of the menstrual cycle. The Heart reat (HR)
recorded beat-to-beat from a one-channel heart monitor (MINISCOPE
II Instramed-Porto Alegre-RS-Brazil), the power and ventilatory
variables were recorded breath-by-breath using an ergospirometer
(CPX/D MedGrafics–Breeze-St.-Paul-Minnesota-USA). The AT was
determined from a visual analysis of the loss of parallelism between
the VO2 and the VCO2. Kruskal-Wallis tests with α = 5% was used. The
mean values of the variables of VO2, Heart rate (HR), and power did
not present a statistical difference (p>0.05) at the peak of the exercise
and at the AT in a comparison of the experimental groups.
Contraceptive therapy of EE combined with gestodene or with
desogestrel did not affect the cardiorespiratory responses.
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